Annual Total Liabilities
$4.14 M
-$6.18 M-59.90%
December 31, 2023
Summary
- As of March 3, 2025, QLGN annual total liabilities is $4.14 million, with the most recent change of -$6.18 million (-59.90%) on December 31, 2023.
- During the last 3 years, QLGN annual total liabilities has fallen by -$6.70 million (-61.81%).
- QLGN annual total liabilities is now -61.81% below its all-time high of $10.83 million, reached on December 1, 2020.
Performance
QLGN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.45 M
-$358.50 K-7.45%
September 30, 2024
Summary
- As of March 3, 2025, QLGN quarterly total liabilities is $4.45 million, with the most recent change of -$358.50 thousand (-7.45%) on September 30, 2024.
- Over the past year, QLGN quarterly total liabilities has stayed the same.
- QLGN quarterly total liabilities is now -81.10% below its all-time high of $23.56 million, reached on September 30, 2020.
Performance
QLGN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
QLGN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.9% | 0.0% |
| 3 y3 years | -61.8% | 0.0% |
| 5 y5 years | -26.8% | 0.0% |
QLGN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.9% | at low | -56.8% | +7.7% |
| 5 y | 5-year | -61.8% | at low | -81.1% | +7.7% |
| alltime | all time | -61.8% | at low | -81.1% | +7.7% |
Qualigen Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.45 M(-7.4%) |
| Jun 2024 | - | $4.81 M(+6.4%) |
| Mar 2024 | - | $4.52 M(+9.4%) |
| Dec 2023 | $4.14 M(-59.9%) | $4.14 M(-30.6%) |
| Sep 2023 | - | $5.96 M(-39.5%) |
| Jun 2023 | - | $9.84 M(+1.3%) |
| Mar 2023 | - | $9.71 M(-5.8%) |
| Dec 2022 | $10.32 M | $10.32 M(+46.5%) |
| Sep 2022 | - | $7.04 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.88 M(+51.8%) |
| Mar 2022 | - | $5.19 M(-17.2%) |
| Dec 2021 | $6.27 M(-42.1%) | $6.27 M(+12.8%) |
| Sep 2021 | - | $5.56 M(-27.1%) |
| Jun 2021 | - | $7.63 M(-19.8%) |
| Mar 2021 | - | $9.51 M(-59.7%) |
| Dec 2020 | $10.83 M(+91.8%) | - |
| Sep 2020 | - | $23.56 M(+7.9%) |
| Jun 2020 | - | $21.83 M |
| Mar 2020 | $5.65 M | - |
FAQ
- What is Qualigen Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual total liabilities year-on-year change?
- What is Qualigen Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly total liabilities year-on-year change?
What is Qualigen Therapeutics annual total liabilities?
The current annual total liabilities of QLGN is $4.14 M
What is the all time high annual total liabilities for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual total liabilities is $10.83 M
What is Qualigen Therapeutics annual total liabilities year-on-year change?
Over the past year, QLGN annual total liabilities has changed by -$6.18 M (-59.90%)
What is Qualigen Therapeutics quarterly total liabilities?
The current quarterly total liabilities of QLGN is $4.45 M
What is the all time high quarterly total liabilities for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly total liabilities is $23.56 M
What is Qualigen Therapeutics quarterly total liabilities year-on-year change?
Over the past year, QLGN quarterly total liabilities has changed by $0.00 (0.00%)